Logo

Jnana Therapeutics Entered into a Second Collaboration and License Agreement with Roche to Discover Small Molecule Drugs

Share this
Jnana Therapeutics Entered into a Second Collaboration and License Agreement with Roche to Discover Small Molecule Drugs

Jnana Therapeutics Entered into a Second Collaboration and License Agreement with Roche to Discover Small Molecule Drugs

Shots:

  • Jnana will receive $50M up front & is eligible to receive near-term milestones & additional future milestones of ~$2B along with royalties
  • Under the terms of the agreement, Jnana will be responsible to conduct discovery & preclinical activities against multiple cancer, immune-mediated & neurological disease targets. Roche will lead the development and commercialization of any resulting products
  • The collaboration allows Jnana to discover novel small molecule drugs directed to targets across a diverse range of target classes in cancer, immune-mediated and neurological diseases by using its RAPID chemoproteomics platform. The collaboration also includes multiple targets to address the unmet medical needs of patients

Ref: Jnana Therapeutics | Image: Roche

Click here to­ read the full press release 

Parag

Parag Narang is a Digital Marketing expert at PharmaShots, He manages the digital marketing as well as the designing ideas for PharmaShots. He has a degree in Bachelor of Business Administration along with Post Graduate Program in Management (Marketing). Parag manages all the social media handles very well since he has a good experience in Marketing & Sales

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions